Pharmaceutical and Medical Device

Johnson & Johnson will soon add new red warning labels to Tylenol bottles sold in the U.S. – alerting users to the serious risks of taking too much of the popular pain reliever.

The Judicial Panel on Multidistrict Litigation (JPMD) has rejected a request to consolidate the growing number of cases against Pfizer Inc. – manufacturer of the controversial cholesterol drug Lipitor – into multidistrict litigation.

According to the Centers for Disease Control and Prevention, more than 54 million Americans — nearly 20% of the population — had difficulty paying medical bills in 2012. Center For Disease Control

Typically, if a bill has not been paid after 120 days, a physician or hospital will turn over the unpaid debt to a collector.

Representing a plaintiff whose hip implant case was assigned to the coordinated DePuy ASR proceedings in San Francisco Superior Court, CaseyGerry opposed a motion by manufacturer Biomet to remand claims based on alleged defects in its products to another trial court.

The legal battles related to labeling for generic drugs rage on.

In 2011, The United States Supreme Court decision, PLIVA, Inc., et al. v. Mensing, gave more power to drug companies – ruling that generic makers cannot be held responsible for failure to warn about a drug’s side-effects, since the generic maker is only making a “copy” of the brand drug and must follow the brand name’s label.

In an effort to draw attention to the need to maintain a high rate of vaccination in this country, the Centers for Disease Control and Prevention has declared this week (April 20-27) National Infant Immunization Week. 

Once a childhood rite of passage, chicken pox has been virtually wiped out since the vaccine was introduced in 1995. Chicken Pox Vaccine Story

A new study conducted by Kaiser researchers and published in Pediatrics, a medical journal for the American Academy of Pediatrics, Effectiveness Story assesses the effectiveness of the chicken pox vaccine and confirms that it offers long term protection against disease.

According to studies from the National Association of Women Lawyers (NAWL), http://www.nawl.org/ females are still significantly underrepresented in law firm leadership roles. While females comprise nearly 35 percent of all attorneys, women account for just 15 percent of equity partners — a level that has not changed in over five years.